Lawrence Corey

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 126 papers. Top paper: “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial”.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders

Journal of Clinical Microbiology(1999)10.1128/jcm.37.4.1113-1116.1999

N/A

9.6DataRank · unranked

123 citations

Meei-Li Huang, Ederlyn E. Atienza, James M. Ferrenberg, Lawrence Corey, Ajit P. Limaye

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

New England Journal of Medicine(2021)10.1056/nejmoa2105290

N/A

7.5DataRank · unranked

684 citations

Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb, Lawrence Corey +40 more

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Scientific Reports(2021)10.1038/s41598-021-03154-6

N/A

3.8DataRank · unranked

80 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0

N/A

2.7DataRank · unranked

91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine(2021)10.1056/nejmoa2035389

N/A

1.4DataRank · unranked

10600 citations

Hana M. El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak +32 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

PLoS Medicine(2020)10.1371/journal.pmed.1003038

N/A

1.2DataRank · unranked

48 citations

Zoe Moodie, Kristen W. Cohen, Nicole Grunenberg, Linda‐Gail Bekker, Mary Allen +26 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months

Journal of Clinical Investigation(2022)10.1172/jci160565

N/A

1.1DataRank · unranked

33 citations

Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck +18 more

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

PLoS Medicine(2021)10.1371/journal.pmed.1003868

N/A

1.1DataRank · unranked

25 citations

Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia-Morales +11 more

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

JCI Insight(2020)10.1172/jci.insight.137079

N/A

1.0DataRank · unranked

49 citations

Srilatha Edupuganti, Yunda Huang, Xue Han, Marnie Elizaga, Edith Swann +23 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445

N/A

0.872DataRank · unranked

36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more

Prospects for a safe COVID-19 vaccine

Science Translational Medicine(2020)10.1126/scitranslmed.abe0948

N/A

0.843DataRank · unranked

274 citations

Lawrence Corey, Prabhavathi Fernandes, Peter B. Gilbert, Peter J. Hotez, Srinivas Rao +5 more

Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads

PLoS Computational Biology(2021)10.1371/journal.pcbi.1009072

N/A

0.835DataRank · unranked

26 citations

Christine Johnston, Jackson Orem, Fred Okuku, Meei‐Li Huang, Habibur Rahman +7 more

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00263-1

N/A

0.750DataRank · unranked

24 citations

Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen +95 more

Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region

Journal of Global Health(2023)10.7189/jogh.13.06020

N/A

0.671DataRank · unranked

19 citations

Jorge A. Gallardo-Cartagena, Deborah Theodore, Portia Hunidzarira, Juan José Montenegro-Idrogo, Jiani Hu +17 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00036-5

N/A

0.530DataRank · unranked

10 citations

Shuying S. Li, Nicole Grunenberg, Edgar T. Overton, Samuel T. Robinson, Hua Zheng +20 more

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Estimating the Risk of Human Herpesvirus 6 and Cytomegalovirus Transmission to Ugandan Infants from Viral Shedding in Saliva by Household Contacts

Viruses(2020)10.3390/v12020171

N/A

0.510DataRank · unranked

29 citations

Elizabeth M. Krantz, Anna Wald, Lawrence Corey, Corey Casper, Soren Gantt +2 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01

JAIDS Journal of Acquired Immune Deficiency Syndromes(2020)10.1097/qai.0000000000002272

N/A

0.413DataRank · unranked

11 citations

Yuanyuan Zhang, Robert Bailer, Nicole Grunenberg, Lindsay N. Carpp, Kelly Seaton +7 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Vaccine Induction of Heterologous HIV-1 Neutralizing Antibody B Cell Lineages in Humans

medRxiv(2023)10.1101/2023.03.09.23286943

N/A

0.376DataRank · unranked

7 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +38 more

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals

medRxiv(2024)10.1101/2024.03.15.24304305

N/A

0.375DataRank · unranked

7 citations

Wilton B. Williams, Stephen R. Walsh, Derek W. Cain, Matthew Clark, Ryan Tuck +38 more

The potential of broadly neutralizing antibodies for HIV prevention

Journal of the International AIDS Society(2024)10.1002/jia2.26257

N/A

0.360DataRank · unranked

10 citations

Lawrence Corey, Dan H. Barouch, Huub C. Gelderblom

Expansion of the HSV-2–specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine

JCI Insight(2024)10.1172/jci.insight.179010

N/A

0.353DataRank · unranked

8 citations

Alvason Zhenhua Li, Kerry J. Laing, Lichun Dong, Kurt Diem, Lichen Jing +15 more

Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns

medRxiv(2024)10.1101/2024.10.15.24315548

N/A

0.299DataRank · unranked

2 citations

Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen, Deirdre Josipovic, Vuyelwa Baba +18 more

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00012-8

N/A

0.292DataRank · unranked

6 citations

Carmen A. Paez, Chenchen Yu, Shelly Karuna, Theresa Gamble, Maurine D. Miner +32 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

Emerging Microbes & Infections(2025)10.1080/22221751.2025.2485317

N/A

0.260DataRank · unranked

4 citations

Shuying Sue Li, Elena Giorgi, LaTonya D. Williams, One Dintwe, Lindsay N. Carpp +34 more

Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns

Journal of Clinical Investigation(2025)10.1172/jci186927

N/A

0.208DataRank · unranked

3 citations

Kennedy Otwombe, William O. Hahn, Shi‐Yu Chen, Deirdre Josipovic, Vuyelwa Baba +18 more

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2025)10.1016/j.cell.2025.10.023

N/A

0.165DataRank · unranked

2 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +43 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Clinical Infectious Diseases(2025)10.1093/cid/ciaf558

N/A

0.104DataRank · unranked

1 citations

Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez +37 more

Distinct immune responses in people living with HIV following SARS-CoV-2 recovery

Communications Medicine(2025)10.1038/s43856-025-00839-1

N/A

0.104DataRank · unranked

1 citations

Shuying Sue Li, Daniel J. Schuster, Xiaohong Li, Jiani Hu, Shelly Karuna +24 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

Journal of the International AIDS Society(2023)10.1002/jia2.26118

N/A

0DataRank · unranked

11 citations

Fei Gao, James P. Hughes, Brett Hanscom, Lawrence Corey, Myron S. Cohen +9 more

Increased frequency and quantity of mucosal and plasma cytomegalovirus replication among Ugandan Adults Living with HIV

PLoS ONE(2023)10.1371/journal.pone.0287516

N/A

0DataRank · unranked

5 citations

Jeffrey N. Bone, Jackson Orem, Fred Okuku, Mary Kalinaki, Misty Saracino +9 more

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad069

N/A

0DataRank · unranked

10 citations

Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy +19 more

Using Haplotype-Based Artificial Intelligence to Evaluate SARS-CoV-2 Novel Variants and Mutations

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.0191

N/A

0DataRank · unranked

3 citations

Seth A. Cohen, Michael Zhao, Margaret M. Madeleine, Thomas H. Payne, Terry P. Lybrand +4 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

UNC Libraries(2023)10.17615/5a1m-e268

N/A

0DataRank · unranked

0 citations

Wang Yao Feng, D.C. Montefiori, Haajira Kaldine, Valerie Bekker, Georgia D. Tomaras +41 more

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

UNC Libraries(2023)10.17615/q13b-q658

N/A

0DataRank · unranked

0 citations

Srilatha Edupuganti, Shelly Karuna, Michal Juraska, Nonhlanhla N. Mkhize, P. Andrew +16 more

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

UNC Libraries(2023)10.17615/wz35-3h79

N/A

0DataRank · unranked

0 citations

Michael P. Fay, Dean Follmann, Deborah Donnell, James G. Kublin, Myron S. Cohen +24 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa

UNC Libraries(2023)10.17615/dzk5-b427

N/A

0DataRank · unranked

0 citations

Glenda Gray, Carl Lombard, Lindsay N. Carpp, Gita Ramjee, P.B. Gilbert +3 more

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2024)10.1016/j.cell.2024.04.033

N/A

0DataRank · unranked

50 citations

S. Munir Alam, Gilad Ofek, Nathaniel Erdmann, David C. Montefiori, Michael S. Seaman +43 more

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies

The Journal of Experimental Medicine(2024)10.1084/jem.20240604

N/A

0DataRank · unranked

29 citations

K. Rachael Parks, Mingchao Shen, Gabriel Ozorowski, Holly Janes, Lamar M. Fleming +32 more

Is HIV epidemic control by 2030 realistic?

The Lancet HIV(2024)10.1016/s2352-3018(24)00098-5

N/A

0DataRank · unranked

28 citations

Georgia D Tomaras, Huub C Gelderblom, Glenda E Gray, Holly Janes, Linda‐Gail Bekker +5 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2308942121

N/A

0DataRank · unranked

21 citations

Hongjun Bai, Allan C. deCamp, Craig A. Magaret, Li Li, Kevin Gillespie +37 more

Anti–PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers

Journal of Clinical Investigation(2024)10.1172/jci169309

N/A

0DataRank · unranked

21 citations

Yoshinori Fukazawa, Christopher W. Peterson, Françoise Haeseleer, Manuel Medina, Shelby Hoffmeister +17 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Open Forum Infectious Diseases(2024)10.1093/ofid/ofad673

N/A

0DataRank · unranked

4 citations

Xiaoying Shen, R. Scott McClelland, Zijun Wang, Stacy Selke, Chloe Wilkens +11 more

Long-term safety and efficacy of COVE study open-label and booster phases

Research Square(2024)10.21203/rs.3.rs-3900939/v1

N/A

0DataRank · unranked

0 citations

Hana M. El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Cynthia Strout +19 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

UNC Libraries(2024)10.17615/18qe-2h49

N/A

0DataRank · unranked

0 citations

Fichtenbaum C.J, Youyi Fong, Isabel Reeder, Gilbert P.B., Spyros A. Kalams +34 more

Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.04.626896

N/A

0DataRank · unranked

0 citations

Ian Hayman, Kristy Derr, Paige Derr, Shayne Frebert, Zina Itkin +10 more

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae558

N/A

0DataRank · unranked

0 citations

L. W. Preston Church, Colleen F. Kelley, Samuel T. Robinson, Yiwen Lu, Briana D. Furch +13 more

Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents

Nature Communications(2025)10.1038/s41467-025-64245-w

N/A

0DataRank · unranked

7 citations

Ian Hayman, Kristy Derr, Paige Derr, Shayne Frebert, Zina Itkin +10 more

Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge

Vaccines(2025)10.3390/vaccines13030231

N/A

0DataRank · unranked

2 citations

Marina Tuyishime, Natasha S. Kelkar, Yunfei Wang, Robert Parks, Sampa Santra +25 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2025)10.17615/t225-p023

N/A

0DataRank · unranked

0 citations

Hong Zhao, Lennie Chen, Li Li, Wenjie Deng, Tanmoy Bhattacharya +37 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

UNC Libraries(2025)10.17615/8kk4-f682

N/A

0DataRank · unranked

0 citations

Jared M. Baeten, Deborah Donnell, Glenda Gray, Linda‐Gail Bekker, Srilatha Edupuganti +9 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study

PLOS Global Public Health(2025)10.1371/journal.pgph.0005156

N/A

0DataRank · unranked

0 citations

Shuying Sue Li, Jiani Hu, Samuel T. Robinson, Zaheer Hoosain, Nigel Garrett +16 more

Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf503

N/A

0DataRank · unranked

0 citations

Angela Campbell, Hu Xie, Chikara Ogimi, Alpana Waghmare, Jane Kuypers +12 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

CMV viral load kinetics as surrogate endpoints after allogeneic transplantation

Journal of Clinical Investigation(2020)10.1172/jci133960

N/A

0DataRank · unranked

55 citations

Brian D. Williamson, Bhavesh Borate, Jonathan L. Golob, Chiara Wychera, Terry Stevens‐Ayers +12 more

Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1863

N/A

0DataRank · unranked

19 citations

Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, Peter B. Gilbert, Dan-Yu Lin

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

Scientific Reports(2020)10.1038/s41598-020-57491-z

N/A

0DataRank · unranked

24 citations

Fatima Laher, Zoe Moodie, Arthur S. McMillan, Rachel L. Spreng, Peter B. Gilbert +15 more

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Vaccines(2020)10.3390/vaccines8040741

N/A

0DataRank · unranked

27 citations

Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang +21 more

The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies

EBioMedicine(2020)10.1016/j.ebiom.2020.103102

N/A

0DataRank · unranked

7 citations

Eshan U. Patel, Charles Kirby, Jacquie Astemborski, Gregory D. Kirk, Shruti H. Mehta +11 more

Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine

Vaccine(2020)10.1016/j.vaccine.2020.06.043

N/A

0DataRank · unranked

4 citations

Jason Shao, Gabriela Diaz, Paul T. Edlefsen, Richard M. Novak, Kenneth H. Mayer +9 more

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

Evaluating the Efficacy of COVID-19 Vaccines

medRxiv(2020)10.1101/2020.10.02.20205906

N/A

0DataRank · unranked

11 citations

Donglin Zeng, Devan V. Mehrotra, Lawrence Corey, Peter B. Gilbert, Dan-Yu Lin

B cells and HSV-specific antibodies respond to HSV-2 reactivation in skin

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.08.192542

N/A

0DataRank · unranked

0 citations

Anton M. Sholukh, RuthMabel Boytz, Savanna S. Carmack, Alexis Klock, Khamsone Phasouk +9 more

Meeting Report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017

(2020)10.14293/111.000/000010.v1

N/A

0DataRank · unranked

0 citations

Linda‐Gail Bekker, Tamara Kredo, Niresh Bhagwandin, Lawrence Corey, Glenda Gray +1 more

Human rights and fair access to COVID-19 vaccines: the International AIDS Society–Lancet Commission on Health and Human Rights

The Lancet(2021)10.1016/s0140-6736(21)00708-x

N/A

0DataRank · unranked

55 citations

Pascale Allotey, Joseph J Amon, Stefan Baral, Mary T. Bassett, Harriet Deacon +18 more

Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes

Frontiers in Immunology(2021)10.3389/fimmu.2021.735643

N/A

0DataRank · unranked

38 citations

Khamsone Phasouk, Catherine Sodroski, Sijie Sun, Yon Hwangbo, Erik D. Layton +17 more

Distinct populations of antigen-specific tissue-resident CD8+ T cells in human cervix mucosa

JCI Insight(2021)10.1172/jci.insight.149950

N/A

0DataRank · unranked

32 citations

Khamsone Phasouk, Emily L. Bossard, Alexis Klock, Lei Jin, Kerry J. Laing +14 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin

Journal of Clinical Investigation(2021)10.1172/jci142088

N/A

0DataRank · unranked

25 citations

Anton M. Sholukh, RuthMabel Boytz, Savanna S. Carmack, Alexis Klock, Khamsone Phasouk +9 more

CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100322

N/A

0DataRank · unranked

14 citations

Corinne M. Mar, Paurvi Shinde, Feinan Wu, Ting Hong, Evan Greene +47 more

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

Viruses(2021)10.3390/v13101921

N/A

0DataRank · unranked

19 citations

Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth M. Krantz, Elizabeth R. Brown +10 more

Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.008

N/A

0DataRank · unranked

8 citations

Yoshinori Fukazawa, Haesun Park, Benjamin Varco-Merth, Blake J. Rust, Jeremy Smedley +9 more

The path to find an HIV vaccine

Journal of the International AIDS Society(2021)10.1002/jia2.25749

N/A

0DataRank · unranked

11 citations

Lawrence Corey, Glenda Gray

High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron

medRxiv(2021)10.1101/2021.12.20.21268130

N/A

0DataRank · unranked

135 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +10 more

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

medRxiv(2021)10.1101/2021.10.05.21264567

N/A

0DataRank · unranked

37 citations

Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández +29 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Research Square(2021)10.21203/rs.3.rs-862572/v1

N/A

0DataRank · unranked

10 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

medRxiv(2021)10.1101/2021.09.09.21263049

N/A

0DataRank · unranked

2 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Nature Medicine(2022)10.1038/s41591-022-01953-6

N/A

0DataRank · unranked

129 citations

Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret +42 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir

Clinical Infectious Diseases(2022)10.1093/cid/ciac868

N/A

0DataRank · unranked

72 citations

William Simmons, Ellora Karmarkar, Leah H Yoke, Ayodale B Braimah, Johnnie J. Orozco +15 more

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

npj Vaccines(2022)10.1038/s41541-022-00535-4

N/A

0DataRank · unranked

61 citations

Lawrence Corey, Jeffrey I. Cohen, Blossom Damania, Anne A. Gershon, David C. Kaslow +10 more

Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19

JCI Insight(2022)10.1172/jci.insight.158402

N/A

0DataRank · unranked

21 citations

Shelly Karuna, Caroline Brackett, Martina S. Wesley, Shuying S. Li, Nathan Eisel +20 more

HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens

Frontiers in Immunology(2022)10.3389/fimmu.2022.867962

N/A

0DataRank · unranked

33 citations

Lichun Dong, Lichen Jing, Kerry J. Laing, Jia Zhu, Lei Jin +8 more

Accelerating clinical trial development in vaccinology: COVID-19 and beyond

Current Opinion in Immunology(2022)10.1016/j.coi.2022.102206

N/A

0DataRank · unranked

16 citations

Maurine D. Miner, Lawrence Corey

Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial

Clinical Infectious Diseases(2022)10.1093/cid/ciac824

N/A

0DataRank · unranked

13 citations

Tsion Andine, Nivashnee Naicker, Jienchi Dorward, Nishanta Singh, Elizabeth Spooner +12 more

Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia

Journal of Clinical Investigation(2022)10.1172/jci161109

N/A

0DataRank · unranked

6 citations

Anton M. Sholukh, Andreas Wieland, David L. Jaye, Mary Carrington, Meei‐Li Huang +11 more

Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.15984

N/A

0DataRank · unranked

4 citations

Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kathleen M. Neuzil, Lawrence Corey +7 more

Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.11.004

N/A

0DataRank · unranked

3 citations

Françoise Haeseleer, Joe Hou, Lawrence Corey, Daniel Corey

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.06.22.22276362

N/A

0DataRank · unranked

15 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial

medRxiv(2022)10.1101/2022.04.18.22271936

N/A

0DataRank · unranked

14 citations

Holly Janes, Olive D. Buhule, Honghong Zhou, Bethany Girard, Kristen Marks +8 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine

medRxiv(2022)10.1101/2022.02.04.22270210

N/A

0DataRank · unranked

2 citations

Alvason Li, Kerry J. Laing, Lichun Dong, Kurt Diem, Lichen Jing +14 more

Novel engineered chimeric engulfment receptors trigger T-cell effector functions against SIV infected CD4+ T cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.21.495546

N/A

0DataRank · unranked

1 citations

Françoise Haeseleer, Lawrence Corey, Daniel Corey

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Nature Communications(2023)10.1038/s41467-022-35768-3

N/A

0DataRank · unranked

102 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

npj Vaccines(2023)10.1038/s41541-023-00630-0

N/A

0DataRank · unranked

40 citations

Youyi Fong, Holly Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule +37 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more